Ovarian cancer radiotherapy

Most of the malignant ovarian tumors, radiation therapy for various effects are poor. Therefore, in the treatment of malignant ovarian tumor was not first consider radiotherapy. After laparotomy confirmed to be malignant ovarian tumor resection not all, in vitro viable X-ray irradiation. But many of ascites are not OK radiotherapy; The abdominal tumor metastasis to the effect of not limited to those within the pelvic cavity. X-ray irradiation is also used in vitro malignant ovarian tumor before and after surgery. Preoperative radiotherapy for patients with radiation therapy after the word four to six weeks should surgery again night, while radiation caused by adhesions, surgery often caused difficulties. Surgery will be in regular radiation treatment after two weeks before and after the start, such as whole body ill patients should first correct.
(1), abdominal irradiation radiation field including full pots of abdominal viscera, or by Ono divided into two to four vertical irradiation of Ono, tumor dose of 25 Gy ~ / 6 to 8 weeks. General liver, kidney tolerance were 30 Gy and 18 Gy, such as the super-dose, should shielding protection. Whole abdominal irradiation after Ono, the largest general tolerance of 30 Gy / 6 to 7 weeks. This dose is not LD50 of ovarian cancer, while Ono irradiation reaction, difficult patient tolerance. Delcios in 1963, a fully mobile strip abdominal irradiation in the treatment of ovarian cancer. Each abdominal irradiation of 10 cm, radiation field from the upward movement in the entire basin to include abdominal, each irradiation in 12 days. Tumor radiation dose of 26 to 28 Gy. The biological effects of radiation and improve the patient's response to radiotherapy.
(2), pelvic tumor irradiation dose of 40 to 60 Gy, 6 to 8 weeks to complete.
(3), plus whole abdominal pelvic irradiation Ono whole abdominal irradiation may be, or transfer surgery strip irradiation dose with the former. Pelvic organ tolerance, to improve efficacy, and pelvic irradiation dose of 20 to 30 Gy, ovarian cancer is the commonly used method.
(4), abdominal radionuclide therapy for patients early preventive treatment, and only a small residual tumor after treatment. Surgery not cut net of malignant ovarian tumor metastases can be injected with the radioactive colloid 98 or 32 P, or diluted with saline injected into the abdominal cavity to prevent cancer formation of ascites, malignant ovarian cancer has been with ascites, the catheter may produce ascites part, to be injected colloidal gold 98 or 32 P . It should be noted 98 of the radioactive colloid and 32 P for intraperitoneal injection, also caused radioactive hepatitis possible, it should be repeated in application check liver function for timely processing.

Tags: abdominal, body, cancer, cause, days, dose, early, eat, ert, gene, injection, intraperitoneal, irradiation, malignant, metastasis, method, ovarian, patients, pelvic, poor, preventive, radiation, radiotherapy, resection, residual, response, surgery, therapy, time, treatment, tumor, tumors

Ovarian cancer and vascular endothelial growth factor related

Fourth Military Medical University Xijing Hospital maternity doctor completed a Biochemistry and the National Natural Science Foundation-funded projects that vascular endothelial growth factor in epithelial ovarian cancer and the formation of blood vessels play an important role.

Biochemistry and immunohistochemical methods used to detect 37 cases of epithelial ovarian cancer of vascular endothelial growth factor expression showed that ovarian cancer and vascular endothelial growth factor related. Therefore, the use of anti-vascular endothelial growth factor-card issuers ribozyme eukaryotic expression vector, in ovarian cancer-specific antibody-mediated tumor cell block under the vascular endothelial growth factor expression levels of genes in the treatment of ovarian cancer provides a strong basis.

Tags: anti, blood, body, cancer, cases, cell, eat, gene, growth, method, ovarian, treatment, tumor

Two new studies provided information on the latest news of ovarian cancer

【Medical industry network HealthDayNews2003 According to the July 3 - now on the younger female epithelial ovarian cancer, some important information: your chances of survival much more than older patients.

In July, "Obstetrics and Gynecology" (Obstetrics andGynecology), the journal published a new study, the researchers found: diagnosis of advanced epithelial ovarian cancer in women aged under 45 of the 5-year survival than those over the age of 45 is two times bigger. "If all other aspects of the same, young patients can live better," the author, Stamford University professor Chen (JohnChan): In fact, even if it is possible to study the impact of factors, such as other health problems, age patients still live better.

Tags: age, blood, cancer, clinical, diagnosis, early, gene, group, groups, growth, method, ovarian, patients, positive, rate, response, study, surgery, survival, time, tumor, women

Common symptoms of ovarian cancer diagnosis and

In recent decades, the treatment of gynecologic cancer progress has been made, but only the ovarian cancer there is no significant improvement. The incidence of ovarian cancer Habitat Gynecologic Oncology third, but it was the first fatality rate. Its cause high mortality due to the growth of ovarian cancer site concealment, not be seen directly, patients still in the early stages of the lack of simple and practical method of diagnosis. Most (about 70%) have been newly diagnosed patients with peritoneal metastasis pots. Currently taken by surgery, radiotherapy, chemotherapy and immunotherapy for the treatment of Chinese medicine integrated with the right therapy, in the treatment of advanced worse still, it is difficult to avoid recurrence. But by early diagnosis and treatment of patients with ovarian cancer prognosis is quite different. Case in epithelial ovarian cancer, according to statistics, the five-year survival rate, 80% for stage I, 40% for Stage II; While Ⅲ period just below 5%. Visibility early detection, early diagnosis and treatment of patients with ovarian cancer is a lifetime event.

Tags: abdominal, age, annex, anti, bleeding, cancer, carcinoma, cases, cause, chemotherapy, clinical, cyst, cystic, diagnosis, diet, early, eat, ert, examination, family, fat, growth, gynecological, history, incidence, increased, life, malignant, mass, metastasis, method, oppression, ovarian, pain, patients, pelvic, poor, prognosis, protein, quality, radiotherapy, rate, reduce, resection, surface, surgery, survival, symptoms, therapy, time, treatment, tumor, tumors, women

Recurrent ovarian cancer chemotherapy new method - conventional chemotherapy drug efficacy forecast molecular targeted chemotherapy

Ovarian cancer is the worst prognosis of gynecologic tumors. Patients with advanced epithelial ovarian cancer five-year survival rates generally below 30%, mainly in patients with relapsing most (about 75%), relapse after chemotherapy to poor results.

For the treatment of recurrent ovarian cancer chemotherapy drugs many, no less than 10 species, but only clinical remission rate of 20% to 30%, no progress median survival time (PFS) for 2 to 6 months, the median overall survival (OS) for six to 12 months. Therefore, to improve the efficacy of chemotherapy drugs delay, but the development of new drugs is very difficult, efficient use of existing drugs is an effective way to <BR>.

Tags: cancer, cases, chemotherapy, cisplatin, clinical, drug, drugs, early, eat, exploration, gene, group, method, ovarian, p53, paclitaxel, patients, pmtc, poor, positive, prognosis, rate, second, study, survival, taxol, therapy, time, treatment, tumor, tumors

Early diagnosis of ovarian cancer was found ways

The United States - a study found, abdominal pain and distension, and ovarian cancer-related symptoms, usually in the months before diagnosis will appear. This shows that the use of appropriate methods of early diagnosis of ovarian cancer, timely treatment to reduce deaths.
According to a Reuters report, the University of California research study found that patients with breast cancer and non-cancer than women with ovarian cancer are more vulnerable to representation symptoms, the most notable of these patients are diagnosed in the first half of the abdominal pain and distension. Researchers in the October edition of the American "cancer" on the magazine report said that the current practice is to use general diagnostic imaging abdominal and pelvic imaging and CA125 to confirm the diagnosis of ovarian cancer. The researchers suggested that doctors should consider allowing representation of the above symptoms of ovarian cancer early women do pelvic imaging and CA125 to early treatment.

Tags: abdominal, breast, cancer, diagnosis, early, eat, gene, method, ovarian, pain, patients, pelvic, reduce, study, symptoms, time, treatment, usually, women

PNAS: The United States and find ovarian cancer early detection methods

Researchers in the United States on the 10th reported that they found a blood-screening early detection of ovarian cancer and new ways to its accuracy rate of 95%.
In Las Vegas, Nevada Cancer Institute researchers published this week in the "Journal of the National Academy of Sciences," the report said, they discovered in experiments in the blood of ovarian cancer patients are four species of the overall level of the protein showed a similar pattern. Four proteins leptin, Lactagogue hormone, osteopontin and insulin-like growth factor.

Tags: blood, cancer, early, ert, growth, method, ovarian, patients, protein, rate, screening, women

Diagnosed with ovarian cancer diagnosis

Ovarian cancer early detection, early treatment, the greater the chance of cure. But ovarian cancer early detection more difficult. Usually, women with ovarian cancer no symptoms or mild discomfort, only to the late period before a noticeable symptoms. Scientists are studying the symptoms, identify methods of ovarian cancer. They found blood in the CA-125, a tumor marker in women with ovarian cancer was significantly increased; Ultrasound can also help early detection of diseases.
The census is a large-scale tumors, including prostate, lung, colorectal and ovarian cancer, the evaluation of tumor markers in the blood of the level of CA-125 and transvaginal ultrasound examination in the early diagnosis of ovarian cancer value.

Tags: abdominal, age, bleeding, blood, body, cancer, care, cause, cyst, cysts, diagnosis, early, eat, examination, history, increased, mass, method, ovarian, ovary, pain, patients, pelvic, physical, poor, powder, resection, staging, study, surgery, surgical, symptoms, treatment, tumor, tumors, usually, women

Ovarian cancer difficult and Countermeasures

Ovarian cancer
Tags: age, annex, blood, body, cancer, cases, cell, cells, chemotherapy, clinical, cyst, cystic, diagnosis, drug, drugs, early, eat, examination, fat, mass, method, ovarian, pain, patients, pelvic, poor, prognosis, reduce, resection, study, surgical, symptoms, therapy, time, toxicity, treatment, tumor, tumors, women

You know how many pairs of ovarian cancer

You are interested in the manual open to learning the prevention and treatment of ovarian cancer, you may answer the following questions, which are from the United States, 199 by the latest knowledge of ovarian cancer questionnaire. Facts have proved that the developed countries in Europe and the United States these people are aware of ovarian cancer rarely. Gynecologic Oncology experts say: lack of knowledge of ovarian cancer is the cause of ovarian cancer mortality leapt to the forefront of gynecologic cancer mortality one of the major reasons. How do you these basic knowledge of the number of ovarian cancer?

Tags: abdominal, age, blood, body, breast, cancer, cause, cell, diagnosis, early, eat, ert, examination, family, gene, growth, gynecological, history, incidence, knowledge, life, lymph, metastasis, method, node, ovarian, ovary, pain, patients, pelvic, rate, reduce, risk, screening, survival, symptoms, time, treatment, tumor, tumors, women, wrong